company background image
SMSPHARMA logo

SMS Pharmaceuticals NSEI:SMSPHARMA Voorraadrapport

Laatste prijs

₹300.65

Marktkapitalisatie

₹25.5b

7D

7.1%

1Y

151.2%

Bijgewerkt

03 Nov, 2024

Gegevens

Financiële gegevens bedrijf

SMS Pharmaceuticals Limited

NSEI:SMSPHARMA Voorraadrapport

Marktkapitalisatie: ₹25.5b

SMSPHARMA Overzicht aandelen

SMS Pharmaceuticals Limited produceert en verkoopt actieve farmaceutische ingrediënten (API's) en tussenproducten in India en daarbuiten.

SMSPHARMA fundamentele analyse
Sneeuwvlok Score
Waardering1/6
Toekomstige groei0/6
Prestaties in het verleden4/6
Financiële gezondheid3/6
Dividenden3/6

SMS Pharmaceuticals Limited Concurrenten

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor SMS Pharmaceuticals
Historische aandelenkoersen
Huidige aandelenkoers₹300.65
52 Week Hoogtepunt₹398.00
52 Week Laag₹113.30
Bèta1.22
11 maand verandering-17.43%
3 maanden verandering-3.25%
1 Jaar Verandering151.17%
33 jaar verandering122.54%
5 jaar verandering638.70%
Verandering sinds IPO736.88%

Recent nieuws en updates

SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced That It Will Be Increasing Its Dividend To ₹0.40

Sep 07
SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced That It Will Be Increasing Its Dividend To ₹0.40

Recent updates

SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced That It Will Be Increasing Its Dividend To ₹0.40

Sep 07
SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced That It Will Be Increasing Its Dividend To ₹0.40

SMS Pharmaceuticals' (NSE:SMSPHARMA) Dividend Will Be Increased To ₹0.40

Aug 22
SMS Pharmaceuticals' (NSE:SMSPHARMA) Dividend Will Be Increased To ₹0.40

Earnings Not Telling The Story For SMS Pharmaceuticals Limited (NSE:SMSPHARMA) After Shares Rise 27%

Aug 20
Earnings Not Telling The Story For SMS Pharmaceuticals Limited (NSE:SMSPHARMA) After Shares Rise 27%

SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced That It Will Be Increasing Its Dividend To ₹0.40

Aug 08
SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced That It Will Be Increasing Its Dividend To ₹0.40

What SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) 27% Share Price Gain Is Not Telling You

Jul 04
What SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) 27% Share Price Gain Is Not Telling You

Here's Why SMS Pharmaceuticals (NSE:SMSPHARMA) Can Manage Its Debt Responsibly

Jun 21
Here's Why SMS Pharmaceuticals (NSE:SMSPHARMA) Can Manage Its Debt Responsibly

SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) 25% Share Price Surge Not Quite Adding Up

Feb 29
SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) 25% Share Price Surge Not Quite Adding Up

SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) CEO Compensation Is Looking A Bit Stretched At The Moment

Sep 24
SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) CEO Compensation Is Looking A Bit Stretched At The Moment

SMS Pharmaceuticals' (NSE:SMSPHARMA) Dividend Will Be ₹0.30

Sep 11
SMS Pharmaceuticals' (NSE:SMSPHARMA) Dividend Will Be ₹0.30

SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced A Dividend Of ₹0.30

Aug 28
SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced A Dividend Of ₹0.30

SMS Pharmaceuticals (NSE:SMSPHARMA) Has A Somewhat Strained Balance Sheet

Jun 07
SMS Pharmaceuticals (NSE:SMSPHARMA) Has A Somewhat Strained Balance Sheet

Shareholders May Not Be So Generous With SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) CEO Compensation And Here's Why

Sep 23
Shareholders May Not Be So Generous With SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) CEO Compensation And Here's Why

SMS Pharmaceuticals (NSE:SMSPHARMA) Is Due To Pay A Dividend Of ₹0.30

Sep 15
SMS Pharmaceuticals (NSE:SMSPHARMA) Is Due To Pay A Dividend Of ₹0.30

SMS Pharmaceuticals (NSE:SMSPHARMA) Will Pay A Dividend Of ₹0.30

Sep 01
SMS Pharmaceuticals (NSE:SMSPHARMA) Will Pay A Dividend Of ₹0.30

SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced A Dividend Of ₹0.30

Aug 18
SMS Pharmaceuticals (NSE:SMSPHARMA) Has Announced A Dividend Of ₹0.30

We Think SMS Pharmaceuticals (NSE:SMSPHARMA) Can Stay On Top Of Its Debt

Mar 22
We Think SMS Pharmaceuticals (NSE:SMSPHARMA) Can Stay On Top Of Its Debt

SMS Pharmaceuticals' (NSE:SMSPHARMA) Earnings Are Of Questionable Quality

Jun 03
SMS Pharmaceuticals' (NSE:SMSPHARMA) Earnings Are Of Questionable Quality

Should You Be Adding SMS Pharmaceuticals (NSE:SMSPHARMA) To Your Watchlist Today?

Mar 08
Should You Be Adding SMS Pharmaceuticals (NSE:SMSPHARMA) To Your Watchlist Today?

What Type Of Shareholders Make Up SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Share Registry?

Feb 22
What Type Of Shareholders Make Up SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Share Registry?

The SMS Pharmaceuticals (NSE:SMSPHARMA) Share Price Is Up 185% And Shareholders Are Boasting About It

Feb 08
The SMS Pharmaceuticals (NSE:SMSPHARMA) Share Price Is Up 185% And Shareholders Are Boasting About It

SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Jan 18
SMS Pharmaceuticals Limited's (NSE:SMSPHARMA) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Here's Why SMS Pharmaceuticals (NSE:SMSPHARMA) Has A Meaningful Debt Burden

Dec 09
Here's Why SMS Pharmaceuticals (NSE:SMSPHARMA) Has A Meaningful Debt Burden

Rendement voor aandeelhouders

SMSPHARMAIN PharmaceuticalsIN Markt
7D7.1%2.6%2.3%
1Y151.2%59.1%37.9%

Rendement versus industrie: SMSPHARMA overtrof de Indian Pharmaceuticals industrie, die het afgelopen jaar een rendement 59.1 % opleverde.

Rendement versus markt: SMSPHARMA overtrof de Indian markt, die het afgelopen jaar een rendement opleverde van 37.9 %.

Prijsvolatiliteit

Is SMSPHARMA's price volatile compared to industry and market?
SMSPHARMA volatility
SMSPHARMA Average Weekly Movement8.4%
Pharmaceuticals Industry Average Movement6.3%
Market Average Movement6.3%
10% most volatile stocks in IN Market9.4%
10% least volatile stocks in IN Market4.0%

Stabiele aandelenkoers: De aandelenkoers van SMSPHARMA is de afgelopen 3 maanden volatiel geweest.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 8% ) van SMSPHARMA is het afgelopen jaar stabiel geweest, maar is nog steeds hoger dan 75% van de aandelen Indian.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
19871,197Ramesh Potlurismspharma.com

SMS Pharmaceuticals Limited produceert en verkoopt actieve farmaceutische ingrediënten (API's) en tussenproducten in India en daarbuiten. Het bedrijf biedt anti-retrovirale, anti-inflammatoire, anti-virale, anti-diabetische, anti-schimmel, anti-epileptische, anti-migraine, anti-coagulant, anti-psychotische, anti-aginale en anti-ulcerale producten. Het bedrijf is ook betrokken bij contractonderzoek naar peptiden.

SMS Pharmaceuticals Limited Samenvatting

Hoe verhouden de winst en inkomsten van SMS Pharmaceuticals zich tot de beurswaarde?
SMSPHARMA fundamentele statistieken
Marktkapitalisatie₹25.45b
Inkomsten(TTM)₹569.64m
Inkomsten(TTM)₹7.38b

44.7x

Koers/Winstverhouding

3.4x

P/S-verhouding

Is SMSPHARMA overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
SMSPHARMA resultatenrekening (TTM)
Inkomsten₹7.38b
Kosten van inkomsten₹5.16b
Brutowinst₹2.22b
Overige uitgaven₹1.65b
Inkomsten₹569.64m

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

Nov 08, 2024

Winst per aandeel (EPS)6.73
Brutomarge30.12%
Nettowinstmarge7.71%
Schuld/Eigen Vermogen Verhouding52.4%

Hoe presteerde SMSPHARMA op de lange termijn?

Bekijk historische prestaties en vergelijking

Dividenden

0.1%

Huidig dividendrendement

7%

Uitbetalingsratio